Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Observation of CBD therapy in patients with intractable epilepsy
DRKS00013177Phase 2Recruiting
- Sponsor
- Universitätsklinikum Freiburg
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cannabidiol in epilepsy, sponsored by Universitätsklinikum Freiburg. Started Jun 2019; status: recruiting.
02
Drugs
cannabidiol
03
Conditions
epilepsy
Beyond the preview
Go deeper on DRKS00013177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00013177.